Table 2.
Risk group | ISUP grade group | Gleason Score | Non-metastasic PCa | Metastasic PCa |
---|---|---|---|---|
n (%) | n (%) | |||
Low | Group 1 | ≤6 | 1 (3.33) | 3 (10) |
Intermediate Favorable | Group 2 | 7 (3 + 4) | 1 (3.33) | 3 (10) |
Intermediate Unfavorable | Group 3 | 7 (4 + 3) | - | 2 (6.67) |
High | Group 4 | 8 | 8 (26.67) | 8 (26.67) |
High | Group 5 | 9–10 | 20 (66.67) | 14 (46.67) |
ISUP: international society of urological pathology; PCa: prostate cancer